BioSpace News Archive

Pharm Country

MEBIAS Discovery Receives Grant from NIDA to Advance Its Signaling-Pathway Selective Mu-Opioid Receptor Drug Candidate

Preclinical studies of lead molecules have shown absence of respiratory depression, rewarding behavior, sedation, and constipation associated with traditional opioids

September 24, 2018
·
2 min read
Business

Cytox Expands Collaboration with AIBL to Identify Those Most at Risk to Rapidly Progress to Alzheimer’s

Important research collaboration for pioneering PRS approach to help drug developers running clinical trials identify and stratify between slow and rapid progressors of the disease

September 24, 2018
·
2 min read
Genetown

Foundation Medicine Introduces FoundationOne®Liquid, the Latest Advance in the Company’s Liquid Biopsy Test for Solid Tumors in Patients with Advanced Cancer

FoundationOne Liquid analyzes 70 genes known to drive cancer growth and reports microsatellite instability high (MSI-high) status to inform the use of precision oncology treatments, including immunotherapies, with a simple blood draw

September 24, 2018
·
5 min read
Ping An Unveils AI Technology at International Maritime Silk Road Forum

-- Empowers Smart City and Healthcare

September 24, 2018
·
6 min read
Business

WellCare Elects Former Louisiana Governor Bobby Jindal to Board of Directors

WellCare Health Plans, Inc. (NYSE: WCG) announced today it appointed Bobby Jindal, former governor of Louisiana, to its board of directors.

September 24, 2018
·
2 min read
Business

DelMar Pharmaceuticals Announces Fiscal Year 2018 Annual Financial Results

Company will host a business update conference call on September 25, 2018 at 4:30 PM Eastern Time

September 24, 2018
·
9 min read
Policy

Endo Agrees to Additional Stay of FDA Litigation Following FDA’s Commitment to Use Best Efforts to Finalize Vasopressin Clinical Need Determination By Year End

Endo International plc today announced that it has agreed to an additional stay of its litigation against the U.S. Food and Drug Administration (FDA) until December 31, 2018.

September 24, 2018
·
5 min read
Bio NC

Immunomic Therapeutics CEO to Present at Precision Medicine World Conference (PMWC): Emerging Therapeutics Showcase

Presentation to Highlight UNITE Potential Capabilities in Immuno-Oncology

September 24, 2018
·
3 min read
Policy

Epizyme Announces the U.S. Food and Drug Administration Lifts Partial Clinical Hold on Tazemetostat Clinical Program

Investor Conference Call Scheduled for Today at 8:30 a.m. EDT

September 24, 2018
·
5 min read
Business

Former “Yo-Yo Dieter” Launches Funny, Unfiltered Blog on Weight-loss Surgery

Jennifer Harmon has had it with obesity. After years of failed diets and unflattering photos, she still had more questions than answers about surgical weight-loss options, so she launched a blog called Confessions of a Yo-Yo Dieter.

September 24, 2018
·
1 min read